177 related articles for article (PubMed ID: 35379910)
21. Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants.
Ohi K; Nishizawa D; Shimada T; Kataoka Y; Hasegawa J; Shioiri T; Kawasaki Y; Hashimoto R; Ikeda K
Int J Neuropsychopharmacol; 2020 Apr; 23(3):157-164. PubMed ID: 31900488
[TBL] [Abstract][Full Text] [Related]
22. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
Ikeda M; Takahashi A; Kamatani Y; Momozawa Y; Saito T; Kondo K; Shimasaki A; Kawase K; Sakusabe T; Iwayama Y; Toyota T; Wakuda T; Kikuchi M; Kanahara N; Yamamori H; Yasuda Y; Watanabe Y; Hoya S; Aleksic B; Kushima I; Arai H; Takaki M; Hattori K; Kunugi H; Okahisa Y; Ohnuma T; Ozaki N; Someya T; Hashimoto R; Yoshikawa T; Kubo M; Iwata N
Schizophr Bull; 2019 Jun; 45(4):824-834. PubMed ID: 30285260
[TBL] [Abstract][Full Text] [Related]
23. Genetic risk for schizophrenia is associated with increased proportion of indirect connections in brain networks revealed by a semi-metric analysis: evidence from population sample stratified for polygenic risk.
Dimitriadis SI; Perry G; Lancaster TM; Tansey KE; Singh KD; Holmans P; Pocklington A; Davey Smith G; Zammit S; Hall J; O'Donovan MC; Owen MJ; Jones DK; Linden DE
Cereb Cortex; 2023 Mar; 33(6):2997-3011. PubMed ID: 35830871
[TBL] [Abstract][Full Text] [Related]
24. DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder.
Håvik B; Degenhardt FA; Johansson S; Fernandes CP; Hinney A; Scherag A; Lybæk H; Djurovic S; Christoforou A; Ersland KM; Giddaluru S; O'Donovan MC; Owen MJ; Craddock N; Mühleisen TW; Mattheisen M; Schimmelmann BG; Renner T; Warnke A; Herpertz-Dahlmann B; Sinzig J; Albayrak Ö; Rietschel M; Nöthen MM; Bramham CR; Werge T; Hebebrand J; Haavik J; Andreassen OA; Cichon S; Steen VM; Le Hellard S
PLoS One; 2012; 7(4):e35424. PubMed ID: 22539971
[TBL] [Abstract][Full Text] [Related]
25. Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia.
Restuadi R; Garton FC; Benyamin B; Lin T; Williams KL; Vinkhuyzen A; van Rheenen W; Zhu Z; Laing NG; Mather KA; Sachdev PS; Ngo ST; Steyn FJ; Wallace L; Henders AK; Visscher PM; Needham M; Mathers S; Nicholson G; Rowe DB; Henderson RD; McCombe PA; Pamphlett R; Blair IP; Wray NR; McRae AF
Eur J Hum Genet; 2022 May; 30(5):532-539. PubMed ID: 33907316
[TBL] [Abstract][Full Text] [Related]
26. Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights.
Kushima I; Aleksic B; Nakatochi M; Shimamura T; Okada T; Uno Y; Morikawa M; Ishizuka K; Shiino T; Kimura H; Arioka Y; Yoshimi A; Takasaki Y; Yu Y; Nakamura Y; Yamamoto M; Iidaka T; Iritani S; Inada T; Ogawa N; Shishido E; Torii Y; Kawano N; Omura Y; Yoshikawa T; Uchiyama T; Yamamoto T; Ikeda M; Hashimoto R; Yamamori H; Yasuda Y; Someya T; Watanabe Y; Egawa J; Nunokawa A; Itokawa M; Arai M; Miyashita M; Kobori A; Suzuki M; Takahashi T; Usami M; Kodaira M; Watanabe K; Sasaki T; Kuwabara H; Tochigi M; Nishimura F; Yamasue H; Eriguchi Y; Benner S; Kojima M; Yassin W; Munesue T; Yokoyama S; Kimura R; Funabiki Y; Kosaka H; Ishitobi M; Ohmori T; Numata S; Yoshikawa T; Toyota T; Yamakawa K; Suzuki T; Inoue Y; Nakaoka K; Goto YI; Inagaki M; Hashimoto N; Kusumi I; Son S; Murai T; Ikegame T; Okada N; Kasai K; Kunimoto S; Mori D; Iwata N; Ozaki N
Cell Rep; 2018 Sep; 24(11):2838-2856. PubMed ID: 30208311
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci.
Wiström ED; O'Connell KS; Karadag N; Bahrami S; Hindley GFL; Lin A; Cheng W; Steen NE; Shadrin A; Frei O; Djurovic S; Dale AM; Andreassen OA; Smeland OB
Addiction; 2022 Mar; 117(3):600-610. PubMed ID: 34472679
[TBL] [Abstract][Full Text] [Related]
28. Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia.
Hackinger S; Prins B; Mamakou V; Zengini E; Marouli E; Brčić L; Serafetinidis I; Lamnissou K; Kontaxakis V; Dedoussis G; Gonidakis F; Thanopoulou A; Tentolouris N; Tsezou A; Zeggini E
Transl Psychiatry; 2018 Nov; 8(1):252. PubMed ID: 30470734
[TBL] [Abstract][Full Text] [Related]
29. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.
Liebers DT; Pirooznia M; Seiffudin F; Musliner KL; Zandi PP; Goes FS
Schizophr Bull; 2016 Jul; 42(4):984-91. PubMed ID: 26873889
[TBL] [Abstract][Full Text] [Related]
30. Relationship of common variants in CHRNA5 with early-onset schizophrenia and executive function.
Han W; Zhang T; Ni T; Zhu L; Liu D; Chen G; Lin H; Chen T; Guan F
Schizophr Res; 2019 Apr; 206():407-412. PubMed ID: 30366711
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of social cognitive performance in autism and schizophrenia.
Hajdúk M; Pinkham AE; Penn DL; Harvey PD; Sasson NJ
Autism Res; 2022 Aug; 15(8):1522-1534. PubMed ID: 35460541
[TBL] [Abstract][Full Text] [Related]
32. Exploring Lead loci shared between schizophrenia and Cardiometabolic traits.
He Q; Bennett AN; Liu J; Fan B; Han X; Cheng L; Chen Y; Yang X; Chan KHK
BMC Genomics; 2022 Aug; 23(1):617. PubMed ID: 36008755
[TBL] [Abstract][Full Text] [Related]
33. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
Pries LK; Dal Ferro GA; van Os J; Delespaul P; Kenis G; Lin BD; Luykx JJ; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Şahin Cankurtaran E; Ulusoy Kaymak S; Mihaljevic MM; Andric Petrovic S; Mirjanic T; Bernardo M; Mezquida G; Amoretti S; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Can Saka M; ; Arango C; O'Donovan M; Tosato S; Rutten BPF; Guloksuz S
Epidemiol Psychiatr Sci; 2020 Nov; 29():e182. PubMed ID: 33200977
[TBL] [Abstract][Full Text] [Related]
34. High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.
Vreeker A; Boks MP; Abramovic L; Verkooijen S; van Bergen AH; Hillegers MH; Spijker AT; Hoencamp E; Regeer EJ; Riemersma-Van der Lek RF; Stevens AW; Schulte PF; Vonk R; Hoekstra R; van Beveren NJ; Kupka RW; Brouwer RM; Bearden CE; MacCabe JH; Ophoff RA;
Psychol Med; 2016 Mar; 46(4):807-18. PubMed ID: 26621616
[TBL] [Abstract][Full Text] [Related]
35. Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs.
Ohi K; Sumiyoshi C; Fujino H; Yasuda Y; Yamamori H; Fujimoto M; Shiino T; Sumiyoshi T; Hashimoto R
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513630
[TBL] [Abstract][Full Text] [Related]
36. Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets.
Aoki R; Saito T; Ninomiya K; Shimasaki A; Ashizawa T; Ito K; Ikeda M; Iwata N
Psychiatry Clin Neurosci; 2022 Aug; 76(8):361-366. PubMed ID: 35536160
[TBL] [Abstract][Full Text] [Related]
37. Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study.
Kowalec K; Lu Y; Sariaslan A; Song J; Ploner A; Dalman C; Hultman CM; Larsson H; Lichtenstein P; Sullivan PF
Mol Psychiatry; 2021 Aug; 26(8):4487-4495. PubMed ID: 31712719
[TBL] [Abstract][Full Text] [Related]
38. Ultrarare Coding Variants and Cognitive Function in Schizophrenia.
Creeth HDJ; Rees E; Legge SE; Dennison CA; Holmans P; Walters JTR; O'Donovan MC; Owen MJ
JAMA Psychiatry; 2022 Oct; 79(10):963-970. PubMed ID: 35976659
[TBL] [Abstract][Full Text] [Related]
39. Distinct Polygenic Score Profiles in Schizophrenia Subgroups With Different Trajectories of Cognitive Development.
Dickinson D; Zaidman SR; Giangrande EJ; Eisenberg DP; Gregory MD; Berman KF
Am J Psychiatry; 2020 Apr; 177(4):298-307. PubMed ID: 31838871
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression.
Holen B; Shadrin AA; Icick R; Filiz TT; Hindley G; Rødevand L; O'Connell KS; Hagen E; Frei O; Bahrami S; Cheng W; Parker N; Tesfaye M; Jahołkowski P; Karadag N; Dale AM; Djurovic S; Smeland OB; Andreassen OA
Addict Biol; 2023 Jun; 28(6):e13282. PubMed ID: 37252880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
